Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Total Liabilities

Latest as of September 2025: CN¥3.76 Billion CNY ≈ $550.00 Million USD

Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has total liabilities worth CN¥3.76 Billion CNY (≈ $550.00 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Jilin Aodong Pharmaceutical Group Co Ltd generate cash to assess how effectively this company generates cash.

Jilin Aodong Pharmaceutical Group Co Ltd - Total Liabilities Trend (1993–2024)

This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Jilin Aodong Pharmaceutical Group Co Ltd (000623) asset resilience to evaluate the company's liquid asset resilience ratio.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
International Game Technology PLC NYSE:IGT	USA	$9.23 Billion
PVH Corp NYSE:PVH	USA	$6.54 Billion
Steadfast Group Ltd AU:SDF	Australia	AU$4.29 Billion
Berner Kantonalbank AG SW:BEKN	Switzerland	CHF39.89 Billion
New Hope Corporation Ltd AU:NHC	Australia	AU$894.41 Million
Societe LDC SA PA:LOUP	France	€2.12 Billion
Griffon Corporation NYSE:GFF	USA	$1.95 Billion
Huhtamaki Oyj HE:HUH1V	Finland	€2.64 Billion

Liability Composition Analysis (1993–2024)

This chart breaks down Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Jilin Aodong Pharmaceutical Group Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jilin Aodong Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jilin Aodong Pharmaceutical Group Co Ltd (1993–2024)

The table below shows the annual total liabilities of Jilin Aodong Pharmaceutical Group Co Ltd from 1993 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.72 Billion ≈ $544.30 Million	-21.96%
2023-12-31	CN¥4.77 Billion ≈ $697.49 Million	-1.36%
2022-12-31	CN¥4.83 Billion ≈ $707.14 Million	+19.95%
2021-12-31	CN¥4.03 Billion ≈ $589.52 Million	+5.35%
2020-12-31	CN¥3.82 Billion ≈ $559.60 Million	+13.94%
2019-12-31	CN¥3.36 Billion ≈ $491.12 Million	-1.70%
2018-12-31	CN¥3.41 Billion ≈ $499.60 Million	+159.05%
2017-12-31	CN¥1.32 Billion ≈ $192.86 Million	-10.13%
2016-12-31	CN¥1.47 Billion ≈ $214.59 Million	-34.84%
2015-12-31	CN¥2.25 Billion ≈ $329.31 Million	+102.65%
2014-12-31	CN¥1.11 Billion ≈ $162.50 Million	-23.45%
2013-12-31	CN¥1.45 Billion ≈ $212.28 Million	+20.08%
2012-12-31	CN¥1.21 Billion ≈ $176.78 Million	+22.54%
2011-12-31	CN¥985.86 Million ≈ $144.26 Million	+51.11%
2010-12-31	CN¥652.43 Million ≈ $95.47 Million	+8.41%
2009-12-31	CN¥601.83 Million ≈ $88.07 Million	-5.18%
2008-12-31	CN¥634.74 Million ≈ $92.88 Million	-14.79%
2007-12-31	CN¥744.94 Million ≈ $109.01 Million	-20.97%
2006-12-31	CN¥942.62 Million ≈ $137.94 Million	+13.59%
2005-12-31	CN¥829.84 Million ≈ $121.43 Million	-6.77%
2004-12-31	CN¥890.13 Million ≈ $130.25 Million	+48.31%
2003-12-31	CN¥600.19 Million ≈ $87.83 Million	-8.60%
2002-12-31	CN¥656.68 Million ≈ $96.09 Million	+77.54%
2001-12-31	CN¥369.87 Million ≈ $54.12 Million	+13.74%
2000-12-31	CN¥325.19 Million ≈ $47.59 Million	-30.62%
1999-12-31	CN¥468.69 Million ≈ $68.58 Million	+120.64%
1998-12-31	CN¥212.43 Million ≈ $31.08 Million	-5.81%
1997-12-31	CN¥225.52 Million ≈ $33.00 Million	+26.44%
1996-12-31	CN¥178.36 Million ≈ $26.10 Million	+23.63%
1995-12-31	CN¥144.27 Million ≈ $21.11 Million	+6.66%
1994-12-31	CN¥135.27 Million ≈ $19.79 Million	+15.88%
1993-12-31	CN¥116.73 Million ≈ $17.08 Million	--

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.30 Billion

CN¥22.57 Billion CNY

Market Cap Rank

#4651 Global

#857 in China

Share Price

CN¥18.87

Change (1 day)

+1.07%

52-Week Range

CN¥16.05 - CN¥21.82

All Time High

CN¥24.39